Part 1: Autoimmune Hemolytic Anemia
Thomas G. DeLoughery, MD
Professor of Medicine, Pathology, and Pediatrics, Division of Hematology/Medical Oncology,
Departments of Medicine and Pediatrics, and Division of Laboratory Medicine, Department of
Pathology, Oregon Health Sciences University, Portland, OR
You are called to consult on a patient with end-stage liver disease and anemia. His hematocrit is 25%. He is noted to have a direct antibody test (DAT) that is positive for IgG antibodies but negative for C3. He has a normal lactate dehydrogenase (LDH) level at 185 U/L and a normal reticulocyte count. What is the next step in the management of this patient??